SACCSG HL-2018. Barriers and enablers of a harmonized treatment protocol for childhood and adolescent Hodgkin lymphoma in South Africa.

IF 1.2 4区 医学 Q4 HEMATOLOGY Pediatric Hematology and Oncology Pub Date : 2023-04-01 DOI:10.1080/08880018.2022.2162651
Jennifer Geel, Marc Hendricks, Yasmin Goga, Beverley Neethling, Vutshilo Netshituni, Rema Mathew, Johani Vermeulen, Anel van Zyl, Fareed Omar, Jan du Plessis, Liezl du Plessis, Elelwani Madzhia, Thandeka Ngcana, Thanushree Naidoo, Lizette Louw, Daynia E Ballot, Monika L Metzger
{"title":"SACCSG HL-2018. Barriers and enablers of a harmonized treatment protocol for childhood and adolescent Hodgkin lymphoma in South Africa.","authors":"Jennifer Geel,&nbsp;Marc Hendricks,&nbsp;Yasmin Goga,&nbsp;Beverley Neethling,&nbsp;Vutshilo Netshituni,&nbsp;Rema Mathew,&nbsp;Johani Vermeulen,&nbsp;Anel van Zyl,&nbsp;Fareed Omar,&nbsp;Jan du Plessis,&nbsp;Liezl du Plessis,&nbsp;Elelwani Madzhia,&nbsp;Thandeka Ngcana,&nbsp;Thanushree Naidoo,&nbsp;Lizette Louw,&nbsp;Daynia E Ballot,&nbsp;Monika L Metzger","doi":"10.1080/08880018.2022.2162651","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> Collaborative studies have contributed to improved survival of pediatric Hodgkin lymphoma in well-resourced settings, but few are documented in resource-constrained countries. The South Africa Children's Cancer Study Group initiated harmonization of management protocols in 2015. This article analyzes barriers and enablers of the process. <b>Methods:</b> Clinician-researchers at 11 state-funded pediatric oncology units completed preparatory questionnaires in June 2018. Parameters included infrastructure, access to therapeutic modalities and clinician numbers. A reassessment of 13 sites (two new pediatric oncology unit) in February 2021 ascertained changes in resources and identified challenges to full participation. Questions investigated the presence and quality of diagnostic radiology, availability of surgeons, cytology/pathology options and hematology laboratory facilities. <b>Results:</b> The response rate was 11/11 to survey 1 and 13/13 to survey 2. The anticipated pre-study barriers to participation of pediatric oncology units included time constraints and understaffing. PET-CT was unavailable to two centers. The majority of pediatric oncology units met the minimum criteria to participate. The interim survey confirmed chemotherapy and radiotherapy availability nearly 100% of the time. One site reported improved access to radiotherapy while another reported improved access to PET-CT. Barriers to participation included excessive times to obtain regulatory approvals, time constraints and lack of dedicated research staff. Enablers include the simple management algorithm and communication tools. <b>Conclusion:</b> This study demonstrates that multicenter collaboration and harmonization of management protocols are achievable in a middle-income setting. Minimal funding is required but full participation to run high-quality studies requires more financial investment. Focused funding and increased prioritization of research may address systemic barriers to full participation.</p>","PeriodicalId":19746,"journal":{"name":"Pediatric Hematology and Oncology","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Hematology and Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08880018.2022.2162651","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: Collaborative studies have contributed to improved survival of pediatric Hodgkin lymphoma in well-resourced settings, but few are documented in resource-constrained countries. The South Africa Children's Cancer Study Group initiated harmonization of management protocols in 2015. This article analyzes barriers and enablers of the process. Methods: Clinician-researchers at 11 state-funded pediatric oncology units completed preparatory questionnaires in June 2018. Parameters included infrastructure, access to therapeutic modalities and clinician numbers. A reassessment of 13 sites (two new pediatric oncology unit) in February 2021 ascertained changes in resources and identified challenges to full participation. Questions investigated the presence and quality of diagnostic radiology, availability of surgeons, cytology/pathology options and hematology laboratory facilities. Results: The response rate was 11/11 to survey 1 and 13/13 to survey 2. The anticipated pre-study barriers to participation of pediatric oncology units included time constraints and understaffing. PET-CT was unavailable to two centers. The majority of pediatric oncology units met the minimum criteria to participate. The interim survey confirmed chemotherapy and radiotherapy availability nearly 100% of the time. One site reported improved access to radiotherapy while another reported improved access to PET-CT. Barriers to participation included excessive times to obtain regulatory approvals, time constraints and lack of dedicated research staff. Enablers include the simple management algorithm and communication tools. Conclusion: This study demonstrates that multicenter collaboration and harmonization of management protocols are achievable in a middle-income setting. Minimal funding is required but full participation to run high-quality studies requires more financial investment. Focused funding and increased prioritization of research may address systemic barriers to full participation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
SACCSG hl - 2018。南非儿童和青少年霍奇金淋巴瘤统一治疗方案的障碍和推动因素。
在资源充足的环境中,协作研究有助于提高儿童霍奇金淋巴瘤的生存率,但在资源受限的国家,鲜有文献记载。南非儿童癌症研究小组于2015年启动了管理协议的协调。本文分析了流程的障碍和促成因素。方法:2018年6月,11家国家资助儿科肿瘤单位的临床研究人员完成了前期问卷调查。参数包括基础设施、获得治疗方式和临床医生人数。2021年2月,对13个地点(两个新的儿科肿瘤科)进行了重新评估,确定了资源的变化,并确定了全面参与的挑战。问题调查了诊断放射学的存在和质量,外科医生的可用性,细胞学/病理学选择和血液学实验室设施。结果:调查1的回复率为11/11,调查2的回复率为13/13。预计研究前儿科肿瘤单位参与的障碍包括时间限制和人员不足。两个中心无法使用PET-CT。大多数儿科肿瘤单位符合参与的最低标准。中期调查证实化疗和放疗几乎100%有效。一个地点报告改善了放射治疗的可及性,另一个报告改善了PET-CT的可及性。参与的障碍包括获得监管部门批准的时间过长、时间限制和缺乏专门的研究人员。使能器包括简单的管理算法和通信工具。结论:本研究表明,在中等收入环境下,多中心协作和管理协议的协调是可以实现的。所需资金最少,但全面参与开展高质量研究需要更多的财政投资。集中资助和增加研究的优先次序可能会解决阻碍充分参与的系统性障碍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.60
自引率
5.90%
发文量
71
审稿时长
6-12 weeks
期刊介绍: PHO: Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. Our goal is to make PHO: Pediatric Hematology and Oncology the premier journal for the international community of clinicians and scientists who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders. The journal supports articles that address research in diverse clinical settings, exceptional case studies/series that add novel insights into pathogenesis and/or clinical care, and reviews highlighting discoveries and challenges emerging from consortia and conferences. Clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies and transplantation are of interest. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome. Articles from scientists and clinicians across the international community of Pediatric Hematology and Oncology are considered for publication. The journal is not dependent on or connected with any organization or society. All submissions undergo rigorous peer review prior to publication. Our Editorial Board includes experts in Pediatric Hematology and Oncology representing a wide range of academic and geographic diversity.
期刊最新文献
Hospital acquired venous thromboembolism in children with sickle cell disease. Clonal hematopoiesis of indeterminate potential is rare in pediatric patients undergoing autologous stem cell transplantation. Pseudohyperkalemia in pediatric patients with newly diagnosed hematological malignancies. Utilization of supportive care medications and opportunities for pre-emptive pharmacogenomic testing in pediatric and young adults with leukemia. Hematopoietic Stem Cell Transplantation in Children with Sickle Cell Disease and Thalassemia Major: A National Database Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1